Structure Therapeutics Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Structure Therapeutics Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $1.21M, a 2720.93% increase year-over-year.
- Structure Therapeutics Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $869.00K, a 9.95% decline year-over-year.
- Structure Therapeutics Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $377.00K, a 5.04% decline year-over-year.
- Structure Therapeutics Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $43.00K, a 91.00% decline year-over-year.
- Structure Therapeutics Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $4.53M, a 144.07% increase from fiscal 2024.
- Structure Therapeutics Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $1.85M, a 131.75% increase from fiscal 2023.
- Structure Therapeutics Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $800.00K, a 2324.24% increase from fiscal 2022.
- Structure Therapeutics Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $33.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $1.21M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $869.00K 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $4.53M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $377.00K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $43.00K 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $965.00K 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $1.85M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $397.00K 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $478.00K 10-Q · filed 2025-11-06 | |
| 2024-03-31 | $755.00K 10-Q · filed 2025-11-06 | |
| 2023-12-31 | $800.00K 10-K · filed 2026-02-26 | |
| 2023-09-30 | $473.00K 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $179.00K 10-Q · filed 2024-11-13 | |
| 2023-03-31 | $31.00K 10-Q · filed 2024-11-13 | |
| 2022-12-31 | $33.00K 10-K · filed 2024-03-08 | |
| 2022-09-30 | $29.00K 10-Q · filed 2023-11-17 | |
| 2022-06-30 | $4.00K 10-Q/A · filed 2023-11-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |